INTRODUCTION
With increasing understanding of the pathophysiology of intrauterine growth restriction (IUGR) and advances in techniques for detecting growthrestricted fetuses, the management of IUGR has undergone major changes in the last decade, with a move toward truly individualized assessment, prognosis and management. Selective intrauterine growth restriction (sIUGR) arising in multiple pregnancies, however, presents unique difficulties for management as the needs of one fetus must be weighed against another and the progression of disease is often not directly comparable with growth restriction in singleton pregnancies.
At just the moment when firm information about prognosis is required, the evidence to provide parents with informed choice has been lacking.
Recent advances have focused on the pathophysiological differences between dichorionic and monochorionic pregnancies with respect to sIUGR. Greater understanding of the placental hemodynamics in a monochorionic pregnancy makes it possible to explain the wide spectrum of outcomes in sIUGR in monochorionic pregnancies, which has led to the adoption of a classification system based on umbilical artery Doppler patterns. Using this classification, trials of interventions other than the standard expectant management or elective preterm delivery have been tried and targeted at those most at risk of poor outcomes.
DEFINITION OF SELECTIVE INTRAUTERINE GROWTH RESTRICTION
sIUGR appears to occur at a similar rate in both monochorionic and dichorionic pregnancies at 11-12% [1] , but neurological complications are more common in monochorionic pregnancies affected by sIUGR than dichorionic pregnancies [2] . A variety of criteria for diagnosing sIUGR have been used leading to some variation in reported incidence.
Selective IUGR in twin pregnancies can be measured in percentage discordance between a twin pair in estimated fetal weight (EFW), abdominal circumference or actual birthweight or may be defined as one twin falling below the 10th centile in EFW or actual birthweight [3 && ]. In practice, differences in birth weight are not useful in informing decision-making during pregnancy, and therefore the most clinically relevant definitions of sIUGR utilize EFW. In recent years, most major work has used the EFW less than 10th centile in one twin, which has led to more uniformity in reporting.
Ease of comparison and meta-analysis is critical at a time when we are moving from description of the natural history to trials of interventions for sIUGR in twins.
MANAGEMENT OF SELECTIVE INTRAUTERINE GROWTH RESTRICTION IN DICHORIONIC TWIN PREGNANCIES
sIUGR in dichorionic twins is associated with placental insufficiency as it is in singleton pregnancies, and abnormal umbilical artery or ductus venosus Dopplers are correlated with poor outcomes. sIUGR in dichorionic pregnancies is more strongly associated with preeclampsia than is sIUGR in monochorionic pregnancies, possibly because the pathophysiology of sIUGR in dichorionic pregnancies is more commonly primary placental insufficiency rather than uneven placental share as it is in monochorionic pregnancies [4] . In general, ultrasound surveillance of the affected twin permits elective delivery when deterioration is detected.
The principal dilemma in the management of dichorionic pregnancies affected by sIUGR comes when the IUGR twin is severely compromised at an early gestation. At this time, particularly before 28 weeks, iatrogenic preterm delivery of the otherwise healthy appropriate for gestational age (AGA) twin subjects this baby to the substantial risks of prematurity.
Expectant management, however, carries the risk of intrauterine fetal demise (IUFD) of the IUGR twin. The main risk to the AGA twin is that the demise of the cotwin may lead to preterm delivery. The risk of death or neurological injury in the surviving twin is relatively low. There is a 54% risk of preterm delivery after single IUFD with a 3% risk of IUFD and 2% risk of neurodevelopmental damage after the intrauterine demise of one dichorionic twin [5] .
There is a limited role for selective reduction in dichorionic twin pregnancies affected by sIUGR. For example, sIUGR associated with severe early-onset preeclampsia has been treated with selective termination of the growth-restricted twin, allowing the pregnancy to continue successfully to term [6] .
The plan of management will be based on gestation, condition of both babies, local services available and the wishes of the parents. These discussions are made easier by the relative clarity of the prognosis in sIUGR in dichorionic pregnancies, whereas monochorionic pregnancies are far less predictable.
MONOCHORIONIC PREGNANCIES
The key to defining the clinical course of sIUGR in monochorionic twin pregnancies is in understanding the impact of the monochorionic placental vasculature and interdependent fetal circulations on the underlying disorder of placental insufficiency. Although in dichorionic pregnancies the fetal circulations are entirely independent, in over 95% of monochorionic pregnancies vascular anastomoses exist that permit exchange between the two circulations [7] . Placental dye injection techniques have enabled detailed analysis of anastomotic patterns that can be related to the clinical presentation [8] . Knowledge in this area has improved in recent years allowing a classification of sIUGR pregnancies that permits interventional trials to be targeted at the highest risk groups.
The degree of growth discrepancy in twin pregnancies is linked to the degree of discordance in placental share [9] , and discordance in placental mass should theoretically increase the risk of growth restriction in a linear fashion. At the same time, total placental mass has been found to be lower in KEY POINTS sIUGR in monochorionic pregnancies is caused by unequal placental share but the clinical course is determined by the number, type and size of placental vascular anastomoses.
Uterine artery Doppler flow is correlated with the placental vascular architecture in monochorionic pregnancies and can be used to classify cases of sIUGR.
Active management with cord occlusion or SLPCV can improve the overall survival in early-onset Type II/III sIUGR.
pregnancies affected by both sIUGR and twin-totwin transfusion syndrome (TTTS) compared with those affected by TTTS alone, suggesting that in addition to inequality of placental share, insufficient total placental mass also has a role in the causation of sIUGR in monochorionic pregnancies [10 & ]. Unequal placental sharing is the underlying cause of most sIUGR in monochorionic pregnancies, but unequally shared placentas have also been found that have more tightly connected fetal circulations with more and larger arterioarterial anastomoses [11] . These may be beneficial to the growth-restricted fetuses, allowing their cotwin to compensate to a degree for the insufficiency of their placenta. This close hemodynamic connection also presents special risks to the AGA fetus, which is vulnerable to sudden changes in the smaller cotwin's circulation. Therefore, unequal placental sharing is the usual cause of sIUGR in monochorionic pregnancies, but the clinical outcome is determined as much, if not more, by the number and type of vascular anastomoses between the twins. Table 1 lists the type of placental anastomoses and their clinical implications.
The presence of vascular anastomoses can affect the blood flow in the umbilical artery of the affected twin, and these effects may be observed in the umbilical artery Doppler waveform from early in the pregnancy. In dichorionic or singleton IUGR pregnancies, the progression of placental insufficiency and fetal compromise may be monitored with ultrasound surveillance of umbilical artery Doppler flow. In a monochorionic pregnancy, the umbilical artery flow is significantly affected by the dynamics of the normal twin's placental circulation, and the typical pattern of deterioration may not be observed. Where there is placental insufficiency leading to growth restriction associated with absent end-diastolic flow (EDF) in an independent circulation, further deterioration would normally be anticipated. In a monochorionic twin, the compensatory effect of the cotwin's circulation may delay, even for many weeks, the deterioration that would normally be expected. This means that the umbilical artery Doppler findings do not predict deterioration in the same way that they do in singleton and dichorionic pregnancies.
CLASSIFICATION OF SELECTIVE INTRAUTERINE GROWTH RESTRICTION IN MONOCHORIONIC TWIN PREGNANCIES
Although the incidence of sIUGR is similar between monochorionic and dichorionic pregnancies, unexpected IUFD is more common and serious neurological injury is more common in monochorionic pregnancies affected by sIUGR, even if both twins are live born. The overall incidence of neurological injury is reported to be between 0 and 33% [14 & ]. Demise of one twin is associated with a 15% risk of death and 25% risk of neurodevelopmental impairment in the cotwin due to the acute fetofetal transfusion that may occur at the time of IUFD of the first twin [5] . This makes the ability to predict the deterioration and IUFD critical in the management of monochorionic sIUGR, particularly as most of the available interventions also carry substantial risks to one or both babies.
The umbilical artery Doppler waveform analysis at diagnosis of sIUGR in monochorionic pregnancies, although not predictive of deterioration, is correlated to the placental architecture and thereby also to clinical outcomes. The presence or absence of umbilical artery Doppler end-diastolic flow in the affected twin at the time of diagnosis forms the basis of the classification system proposed by Gratacos et al. (outlined in Table 2 and Fig. 1 ).
Positive EDF is reassuring (Type I) and the absent or reversed end-diastolic flow (AREDF) is a poor prognostic indicator (Type II), as in dichorionic or singleton pregnancies, but the third category of intermittent AREDF (Type III) is unique to monochorionic sIUGR pregnancies. In this group, the presence of large diameter arterioarterial anastomoses permits a cyclical compensatory flow from the normal twin's circulation that can be observed in cyclical improvement in the EDF in the IUGR twin, promoting longer survival of the IUGR twin but also facilitating acute transfusion events that can lead to unexpected IUFD or neurological damage.
MANAGEMENT OF SELECTIVE INTRAUTERINE GROWTH RESTRICTION MONOCHORIONIC PREGNANCIES
The management of sIUGR is guided by classifying the pregnancy according to the umbilical artery Doppler and targeting interventions at the highest risk cases in accordance with the parents' wishes. Type I sIUGR carries an excellent prognosis, and although regular ultrasound surveillance is required, elective delivery at 34-36 weeks is usually possible. In early studies, as few as 2.6% [16] Type I cases were noted to develop AREDF in the remainder of the pregnancy, leading the investigators to conclude that the umbilical artery Doppler findings in the smaller twin at the time of diagnosis are usually stable over time. Although most Type I cases reported do remain stable, recent groups reported progression in 26 [17 && ] and 11.1% [18 & ] of cases, respectively, underlining the importance of regular ultrasound surveillance even in this group.
Type II and III pregnancies have a poorer prognosis and are more likely to require intervention. In Type II sIUGR, between 70 and 90% of cases can be expected to deteriorate [15, 16] , and intact survival is reported at 37% [15] . The umbilical artery Doppler flow is not a useful predictor of the speed of deterioration and IUFD but other ultrasound parameters may be of use, in particular changes in the ductus venosus Doppler [19] and severe oligohydramnios [20] . Severe oligohydramnios was observed to be a predictor of IUFD of the IUGR twin [20] , and some clinicians use changes in the ductus venosus to guide intervention. In general, after 26-28 weeks, the risks of preterm delivery are less than the risks of fetal intervention, depending on the locally available services. Only those sIUGR pregnancies identified prior to the third trimester and with high risk of intrauterine complications may be routinely considered for fetal intervention. The available choices are laser coagulation of the anastomotic connections between the fetal circulations, selective reduction or termination of the whole pregnancy.
The most commonly used treatment, where expectant management is deemed inappropriate, is selective termination via cord coagulation or radiofrequency ablation of the smaller twin. This procedure is relatively straightforward to perform and can protect the AGA twin against neurological injury or death in the event of unexpected IUFD of the smaller cotwin. The clinical outcomes are well described, and most fetal intervention centers have a high degree of familiarity with both techniques. The AGA twin survival in cases of Type II sIUGR managed with selective reduction is reported to be 87-90.9% [21, 22] , giving an overall survival (OS) rate of 43.8-45.4%. The most recent prospective cohort to report outcomes of 90 cases of severe Type II and III sIUGR reported an OS rate of 46.6% with survival of the AGA twin at 93.3% [23 && ]. Selective laser photocoagulation of connecting vessels (SLPCV) of placental vessels is an established treatment for TTTS, and there is understandable interest in the benefit of using this technique in the management of sIUGR in monochorionic pregnancies. There are a number of theoretical advantages including achieving separation of the fetal circulations and protecting the AGA twin without necessarily sacrificing the smaller twin. Unlike in the management of TTTS, however, the anastomotic connections are not the root cause of the growth restriction and in fact may be of net benefit to the smaller twin. Removing from the smaller twin the compensation afforded by the AGA twin circulation may only hasten the IUFD of the smaller twin while protecting the AGA twin from the effects of that event.
SLPCV for sIUGR itself is technically difficult to perform because, unlike in TTTS, both twins have normal liquor volume and the lack of polyhydramnios may make it more difficult to visualize the placental vascular equator. In one study of SLPCV for Type III sIUGR, only 88.9% of procedures were completed [19] because of technical difficulties and 12.5% required a second procedure. The procedure carries a risk of preterm prelabor rupture of membranes, preterm labor and chorioamnionitis. In addition, in monochorionic twins, the procedurerelated incision of the intertwin membrane may occur either deliberately to facilitate access to the vascular equator [19] or incidentally during the procedure, and cases of iatrogenic monoamniotic pregnancies have been reported. Chorioamniotic separation may occur in up to 20% of cases treated fetoscopically and is associated with poorer pregnancy outcomes [24 & ]. The first report of laser for sIUGR in monochorionic pregnancies diagnosed before 26 weeks was published in 2001 [25] and reported similar mortality outcomes compared with expectant management (survival of at least one fetus 72.3 vs 82.3% in the expectant management group) and reduced neurological complications. At this time, no standard classification of sIUGR was in use, but the majority of cases in both groups had AREDF, suggesting that most of the cases could have been classified as Type II.
The Type II cases have the worst clinical prognosis, and therefore presented the first target group for trials of SLPCV for sIUGR. The most recent report included 142 cases of Type II sIUGR and compared them with a cohort of 405 cases with coexisting TTTS undergoing SLPCV [3 && ]. The OS was 53.2% with survival of at least one twin in 71.8% of cases. These results are consistent with the findings of a previous study comparing cases of Type II and III sIUGR together managed by cord occlusion or SLPCV [22] . The survival of the AGA twin after SLPCV seems to be less than after selective reduction (67.6-73.9%), but 30.4-38.7% of the smaller twins survive, contributing to the slight increase in OS with SLPCV compared with cord occlusion.
The sIUGR pregnancies most at risk of unpredictable IUFD and neurological damage are those Type III cases in which the presence of large arterioarterial anastomoses renders each twin vulnerable to ischemic brain damage during even transient episodes of bradycardia and hypotension in their cotwin. Although the OS is higher than in Type II, the lack of ability to predict deterioration in this group means that they might be expected to benefit most from the 'dichorionization' effect of laser treatment. A cohort study compared a group of 18 Type III cases treated with laser to 31 cases managed expectantly and found that in 75% of cases undergoing SLPCV, there was IUFD of the smaller twin, which was usually preceded by the development of abnormal umbilical artery Doppler and ductus venosus after dichorionization of the placenta [19] . It was also observed that the AGA twin in the SLPCV group was less likely to die in the event of IUFD of the cotwin after separation of the circulations. Although a small and retrospective group, these findings are consistent with what is known about the underlying disorder. Conversely and in common with other reports of SLPCV, for sIUGR the group reported one unexpected IUFD in the AGA twin after the procedure, and no physiological explanation for this phenomenon is as yet available.
Several groups have now reported on the use of SLPCV for Type II and III sIUGR but no randomized controlled trial data are as yet available to provide clarity on where the balance of risk and benefit lies. As it stands, it seems that cord occlusion and SLPCV offers similar OS chances, although SLPCV carries a greater risk to the AGA twin while a greater percentage of the smaller twins can survive. An important unanswered question is what the impact of SLPCV is on neurological outcome for both twins. Quintero et al. [25] found a slight improvement in neurological outcomes in their group of 11 treated with SLPCV compared with 17 managed expectantly. Both Chalouhi and Gratacos reported short-term neurological outcomes (periventricular leukomalacia and intraventricular hemorrhage) but in both cases the numbers involved are too small to draw any conclusions. One recent study of SLPCV for 10 cases of Type II sIUGR with severe oligohydramnios reported on neurological outcomes up to 28 days of life and found 30 and 100% intact survival in the IUGR and AGA twins, respectively [26 & ], which although small is consistent with the known physiology and the findings of other groups.
It is to be expected that in keeping with the reduced risk of IUFD of the AGA twin after the IUFD of the smaller twin in cases treated by SLPCV, there should also be reduced risk of neurological injury after separation of the circulations, but that has not yet been demonstrated. Any benefit thus gained would also need to be large enough to outweigh the potential negative neurodevelopmental consequences of preterm delivery due to complications of the endoscopic procedure.
CONCLUSION
Trials comparing selective reduction, laser vessel coagulation and expectant management are fraught with difficulties given the highly variable laws related to termination around the world and the relatively few centers with the necessary technical expertise to participate in such a trial. Recent years have provided a greater understanding of the pathophysiological basis of sIUGR, and early studies have demonstrated the feasibility and potential benefits of SLPCV for monochorionic sIUGR. A large-scale trial is now necessary to provide a definitive guide to the management of these complex pregnancies. In the interim, management strategies will be chosen in discussion with the parents bearing in mind parental ethics, local service capabilities, the gestational age and the Doppler findings of each individual pregnancy.
